In a research note to investors, Buckingham Research Upgraded on Morgan Stanley (NYSE:MS) with a Buy and no price target.
On a consensus level, sell-side research analysts have a consensus price target of 41.870 on the stock. This is the average of the individual targets from the covering analysts polled by Thomson Reuters First Call. Analysts are projecting that the company will report earnings per share of 0.660 for next quarter. For the current year, research firms are anticipating earnings of 3.030 per share.
On a technical level the stock has a 50 Day Moving Average of 38.544. Based on a recent trade, this puts the equity at -14.655% away from that average. In comparing the stock’s current level to its extended history, the stock is trading -19.846% away from its 52 week high of 41.040 and +8.207% away from the stock’s low point over the past 52 weeks, which was 30.400.
The price to earnings ratio, or the valuation ratio of a company’s current share price compared to its per-share earnings sits at 16.740. This is an important indicator as a higher ratio typically suggests that investors are expecting higher future earnings growth compared to companies in the same industry with lower price to earnings ratios. When calculating in the EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at 10.856. Investors looking further ahead, will note that the Price to next year’s EPS is 9.562.
Today the stock opened the current trading session at 33.800 and at the time of writing the last Bid was at 32.895. In the current session the stock reached as high as 33.800 and dipped down to 32.730. Morgan Stanley Common Stock, a NYQ listed company, has a current market cap of 64.26B and on average over the past 3 months has seen 9043430 shares trade hands on a daily basis.